Viviscal occupies an unusual spot in the hair supplement aisle: it actually has published clinical trials behind it, not just marketing copy and a proprietary blend name. At roughly $40 a month it costs about half what Nutrafol does, and it has been sold long enough that its evidence base has had time to accumulate and replicate. That combination — real trials, moderate price — is rare in this category, which is exactly why it deserves a closer look before you decide whether it belongs in your routine.
Quick Answer
Viviscal is a marine-collagen hair supplement with several published randomized, placebo-controlled trials showing increased terminal hair counts at three and six months. At about $40/month it is half the price of Nutrafol with a comparable evidence base. It does not block DHT, so it will not fix a receding hairline, and it is unsuitable for anyone with a fish or shellfish allergy.
What's In It
Viviscal's core active ingredient is AminoMar C, a proprietary marine complex derived from shark cartilage and mollusc (oyster shell) powder. The theory is that these marine-derived proteins and polysaccharides supply amino acids the hair follicle needs to produce a strong hair shaft, nourishing it from the inside rather than acting on a hormonal pathway. It is the ingredient the published trials are actually built around, and it is also the ingredient that makes Viviscal unsuitable for a chunk of the population — more on that below.
Around AminoMar, the formula adds a fairly standard supporting cast:
- Biotin — a B vitamin involved in keratin synthesis, the structural protein hair is made of.
- Vitamin C — supports collagen production and improves absorption of the iron also included in the formula.
- Zinc — a cofactor in follicle-related enzymatic activity; zinc deficiency is independently associated with shedding.
- Iron and niacin — included to cover common nutritional shortfalls that are themselves linked to diffuse thinning, particularly in women.
None of these secondary ingredients are exotic or unique to Viviscal — you could get biotin, vitamin C, and zinc from a $10 multivitamin. What separates Viviscal from a generic multivitamin marketed for hair is that its core complex has actually been tested against placebo in controlled trials, rather than included because the ingredients sound plausible on a label.
What the Trials Actually Found
This is the section that matters, because it's also the section most hair supplements can't produce.
Viviscal has multiple published randomized, double-blind, placebo-controlled trials. A 2012 study in the Journal of Clinical and Aesthetic Dermatology enrolled women with self-perceived thinning hair and found statistically significant increases in terminal hair counts and reductions in shedding compared with placebo. A follow-up 2015 extension study, also published in the Journal of Clinical and Aesthetic Dermatology, replicated the effect over a longer observation window. An earlier trial from 1992 examined a related marine-protein formulation and reported measurable improvements as well, making Viviscal's evidence base unusually long-running for a supplement.
Two things are worth noting about the timeline. First, the trials measured outcomes at roughly 90 and 180 days — three and six months — not sooner. Improvement was not meaningful before the 90-day mark in any of the published work, which tracks the underlying biology: a hair follicle that shifts into an active growth phase today will not produce visible length for months regardless of what you're taking. Second, the effect sizes reported are statistically significant but modest — these are not before-and-after transformations, they are measurable, real, but incremental differences in hair count and shedding rate versus a placebo group.
The honest caveat, and it applies across the entire hair supplement category, not just Viviscal: these trials are small, and several were funded by the manufacturer (Church & Dwight, which owns the Viviscal brand). Manufacturer funding does not automatically invalidate a result — the studies are randomized, double-blind, and peer-reviewed, which are the right controls — but it is a real limitation worth weighing, and it is the same limitation that applies to Nutrafol's clinical evidence. Neither company has funded the kind of large, independent trial that would put the question to rest definitively. Within that constraint, Viviscal's evidence is genuinely better documented than most of its competitors, which is why it keeps showing up at the top of supplement rankings.
Where It Falls Short
It does not block DHT. Viviscal's mechanism is nutritional support of the existing follicle — it does not interfere with the conversion of testosterone to DHT, the hormone primarily responsible for the miniaturization of follicles in androgenetic alopecia. If your hair loss is driven by DHT, Viviscal is not addressing the cause.
It contains marine allergens. The AminoMar complex is derived from shark and mollusc sources, which makes Viviscal unsuitable for anyone with a fish or shellfish allergy, and unsuitable for vegetarians and vegans regardless of allergy status. There is no vegan reformulation of the original complex. This is a hard exclusion, not a minor inconvenience.
It is slow, like every supplement in this category. Three to six months minimum before any measurable change, matching the trial timelines above. There is no faster path with a supplement; the rate-limiting factor is the hair growth cycle itself.
It will not fix a receding hairline. Androgenetic hairline recession is a DHT-driven pattern. Viviscal's nutritional mechanism has no real answer for that pattern. Using Viviscal alone, expecting it to hold or reverse a receding hairline, will cost you six months and very likely disappoint you. For that specific pattern, the evidence points toward finasteride and minoxidil, not a supplement.
Viviscal vs Nutrafol
The two most clinically studied hair supplements on the market work through genuinely different mechanisms, which makes the comparison less about "which is better" and more about "which mechanism matches your situation."
Viviscal's AminoMar marine complex is aimed at nutritional support and follicle nourishment — it does not touch DHT or cortisol. Nutrafol's formula is more mechanistically diverse: it adds saw palmetto (a mild DHT blocker), ashwagandha (an adaptogen aimed at stress-related shedding), and anti-inflammatory botanicals. That broader formula is also part of why Nutrafol costs roughly $88/month versus Viviscal's $40/month.
For diffuse thinning without an obvious hormonal or stress driver, Viviscal is the more cost-effective starting point with comparable published evidence. For hair loss where stress or a mild DHT component is suspected, Nutrafol's additional mechanisms may justify the premium. Neither substitutes for finasteride or minoxidil in confirmed androgenetic alopecia. For the full ingredient-by-ingredient and cost breakdown, see our Nutrafol vs Viviscal comparison.
Who Should Buy It
Viviscal makes the most sense for a fairly specific set of situations, not as a general-purpose hair loss fix.
Diffuse thinning without a clear hormonal driver — if your hair is thinning broadly rather than receding at the hairline or crown, a nutritional approach is more mechanistically relevant than a DHT blocker.
Postpartum or nutritionally-driven shedding — Viviscal has been studied specifically in women with self-perceived thinning hair, and its ingredient profile (iron, zinc, biotin, vitamin C) addresses nutritional gaps that commonly follow pregnancy and breastfeeding.
Budget-conscious buyers who still want documented evidence — at $40/month, Viviscal delivers a meaningfully similar evidence tier to Nutrafol at less than half the annual cost. Over a year that's roughly $480 versus $1,056.
It is not the right choice if you have a fish or shellfish allergy, follow a vegan or vegetarian diet, or are dealing with a receding hairline that needs an actual DHT blocker.
We earn 4%/sale if you sign up · See all commissions
We earn 4%/sale if you sign up · See all commissions
We earn 4%/sale if you sign up · See all commissions
Frequently Asked Questions
Does Viviscal have real clinical evidence?
Yes, more than most supplements in this category. Multiple randomized, double-blind, placebo-controlled trials report statistically significant increases in terminal hair counts over three to six months. The trials are small and several were funded by the manufacturer, which is common in this space and worth weighing, but the methodology is sound and the results have replicated.
How long does Viviscal take to work?
Three to six months. The published trials measured outcomes at 90 and 180 days, and improvement was not meaningful before the 90-day mark. This tracks the hair growth cycle rather than anything specific to Viviscal. Commit to six months or do not start.
Is Viviscal better than Nutrafol?
Neither is clearly superior; they target different drivers. Viviscal's AminoMar marine complex is aimed at nutritional support of the follicle. Nutrafol adds saw palmetto, adaptogens, and anti-inflammatory botanicals, which makes it a better fit when stress or mild DHT involvement is suspected. Viviscal costs about half as much for comparable published evidence.
Can vegetarians or people with fish allergies take Viviscal?
No. The core AminoMar complex is derived from marine sources including shark and mollusc powder, so it is unsuitable for vegetarians, vegans, and anyone with a fish or shellfish allergy. There is no vegan reformulation of the original complex. Consider Nutrafol or a different supplement instead.
Will Viviscal regrow a receding hairline?
Almost certainly not. Viviscal supports existing follicles nutritionally; it does not block DHT, which is what drives hairline recession in androgenetic alopecia. For a receding hairline the evidence points to finasteride and minoxidil. Using Viviscal alone for that pattern will waste six months.
Sources
- Lassus A et al. J Int Med Res. 1992. PMID: 1286738
- Ablon G. A double-blind, placebo-controlled study evaluating the efficacy of an oral supplement in women with self-perceived thinning hair. Journal of Clinical and Aesthetic Dermatology. 2012;5(11):28-34. PMID: 23198010.
- Ablon G, Dayan S. A randomized, double-blind, placebo-controlled, multi-center, extension study evaluating the efficacy of a new oral supplement in women with self-perceived thinning hair. Journal of Clinical and Aesthetic Dermatology. 2015;8(12):15-21. PMID: 26705444.
Affiliate disclosure: We earn a commission if you purchase through the links above. Full methodology.